Prudential Financial
KZR

Prudential Financial’s Kezar Life Sciences KZR Stock Holding History

Prudential Financial’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,898
Closed -$17.1K – 2751
2024
Q1 		$17.1K Hold
1,898
– – ﹤0.01% 2651
2023
Q4 		$17.8K Sell
1,898
-1,755
-48% -$15.4K ﹤0.01% 2621
2023
Q3 		$43.5K Buy
3,653
+670
+22% +$11.9K ﹤0.01% 2513
2023
Q2 		$73.1K Sell
2,983
-5,050
-63% -$131K ﹤0.01% 2499
2023
Q1 		$251K Buy
+8,033
New +$465K ﹤0.01% 2325
2021
Q4 		– Sell
-1,257
Closed -$109K – 2664
2021
Q3 		$109K Buy
1,257
+120
+11% +$7.94K ﹤0.01% 2526
2021
Q2 		$61K Sell
1,137
-2,089
-65% -$119K ﹤0.01% 2511
2021
Q1 		$192K Sell
3,226
-618
-16% -$36.1K ﹤0.01% 2410
2020
Q4 		$201K Sell
3,844
-1,053
-22% -$58.6K ﹤0.01% 2360
2020
Q3 		$237K Buy
4,897
+57
+1% +$2.73K ﹤0.01% 2242
2020
Q2 		$251K Buy
+4,840
New +$244K ﹤0.01% 2179

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Prudential Financial's KZR Position: Q2 2024 in Review

Prudential Financial sold out of Kezar Life Sciences (KZR) in Q2 2024, closing a stake of 1,898 shares — an estimated $17.1K sold.

Prudential Financial first reported a position in KZR in Q2 2020 and held it in 11 quarters. The position peaked at $251K in Q1 2023. 81 funds tracked by Wall St. Rank hold KZR as of Q2 2024.

  • Prudential Financial reported no remaining Kezar Life Sciences position as of Q2 2024 after selling out during the quarter.
  • Prudential Financial sold 1,898 Kezar Life Sciences shares in Q2 2024, an estimated $17.1K.
  • Prudential Financial first reported a position in Kezar Life Sciences in Q2 2020 and held it in 11 quarters.
  • Prudential Financial's Kezar Life Sciences position peaked at $251K in Q1 2023.
  • 81 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2024.

Based on Prudential Financial's 13F filing for Q2 2024, filed 13 Aug 2024.